Holen Sie sich die Stockscreener-App
190.38
1.93%
-3.75
Handel nachbörslich:
190.38
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt THC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$194.13
Offen:
$196.11
24-Stunden-Volumen:
1.24M
Relative Volume:
0.96
Marktkapitalisierung:
$16.40B
Einnahmen:
$21.46B
Nettoeinkommen (Verlust:
$2.65B
KGV:
9.8995
EPS:
19.2312
Netto-Cashflow:
$3.35B
1W Leistung:
+3.88%
1M Leistung:
-4.49%
6M Leistung:
-7.25%
1J Leistung:
+27.72%
1-Tages-Spanne:
$188.88
$198.43
1-Wochen-Bereich:
$177.41
$198.43
52-Wochen-Spanne:
$146.60
$247.21
Tenet Healthcare Corp Stock (THC) Company Profile
Firmenname
Tenet Healthcare Corp
Sektor
Branche
Telefon
469-893-2200
Adresse
14201 DALLAS PARKWAY, DALLAS, TX
Compare THC vs HCA, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
THC
Tenet Healthcare Corp
|
190.38 | 16.40B | 21.46B | 2.65B | 3.35B | 19.23 |
HCA
Hca Healthcare Inc
|
435.19 | 96.54B | 76.39B | 7.81B | 7.93B | 29.08 |
DVA
Davita Inc
|
198.65 | 12.75B | 13.64B | 1.05B | 1.31B | 9.555 |
FMS
Fresenius Medical Care Ag Adr
|
22.03 | 11.83B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
106.10 | 10.53B | 6.07B | 793.80M | 464.40M | 5.9914 |
Tenet Healthcare Corp Stock (THC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-14 | Fortgesetzt | Goldman | Buy |
| 2025-07-28 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-05-29 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-26 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-02-26 | Eingeleitet | TD Cowen | Buy |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-12-16 | Herabstufung | Goldman | Buy → Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-11-22 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Eingeleitet | JP Morgan | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-03-29 | Eingeleitet | Wells Fargo | Overweight |
| 2022-02-10 | Hochstufung | UBS | Neutral → Buy |
| 2022-02-09 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-02-09 | Hochstufung | Truist | Hold → Buy |
| 2022-01-20 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-09-24 | Eingeleitet | UBS | Neutral |
| 2021-08-12 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-07-23 | Fortgesetzt | Citigroup | Buy |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-03 | Fortgesetzt | Goldman | Buy |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2021-01-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-12-15 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-09-21 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-11 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-02-26 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-12-09 | Hochstufung | UBS | Neutral → Buy |
| 2019-11-06 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-08-14 | Fortgesetzt | Goldman | Neutral |
| 2019-02-26 | Bestätigt | BofA/Merrill | Neutral |
| 2019-01-14 | Eingeleitet | Stephens | Equal-Weight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Hold |
| 2018-12-17 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-06-29 | Herabstufung | Jefferies | Buy → Hold |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-30 | Fortgesetzt | Wells Fargo | Market Perform |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-19 | Bestätigt | Mizuho | Neutral |
| 2017-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Tenet Healthcare Corp Aktie (THC) Neueste Nachrichten
Tenet Healthcare Q1 2026 slides: EPS beats amid deleveraging push - Investing.com
Earnings call transcript: Tenet Healthcare posts strong Q1 2026 EPS beat - Investing.com Canada
Tenet Healthcare (THC) Principal Accounting Officer reports 2,584 RSUs on Form 3 - Stock Titan
Why Tenet Healthcare (THC) is a top value stock for the long term - MSN
Why some Belleville-area hospitals are missing from new safety reports - AOL.com
THC Beats Q1 Earnings Estimates on Strong Ambulatory Growth, Ups '26 EPS View - Yahoo Finance
Here is What to Know Beyond Why Tenet Healthcare Corporation (THC) is a Trending Stock - Yahoo Finance
Tenet to Participate in the BofA Securities Health Care Conference - Yahoo! Finance Canada
MSN Money - MSN
Columbia Select Small Cap Value Fund's Tenet Healthcare Corp(THC) Holding History - GuruFocus
Is It Too Late To Consider Tenet Healthcare (THC) After Its Strong Multi‑Year Rally? - Yahoo Finance
THC Maintained by Stephens & Co. -- Price Target Lowered to $260 - GuruFocus
Earnings call transcript: Tenet Healthcare beats Q1 2026 EPS expectations - Investing.com
EDGAR Filing Documents for 0001193125-17-094187 - SEC.gov
Tenet Healthcare (NYSE:THC) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat
THC Q1 Deep Dive: Hospital Margins Improve Despite Exchange Headwinds and Flat Volumes - Yahoo Finance
Tenet Healthcare Q1 Earnings Call Highlights - MarketBeat
Tenet Healthcare Corp (NYSE:THC) Emerges as a Decent Value Candidate with Strong Fundamentals - ChartMill
Tenet Healthcare Shines In Q1 2026 Earnings Call - The Globe and Mail
THC Maintained by RBC Capital -- Price Target Lowered to $236 - GuruFocus
THC Maintains Overweight Rating by Wells Fargo -- Price Target L - GuruFocus
Is Tenet Healthcare Corp (THC) Overvalued After 3.5% Rally? GF V - GuruFocus
Tenet Healthcare (NYSE:THC) Price Target Cut to $236.00 by Analysts at Royal Bank Of Canada - MarketBeat
THC Maintained by Keybanc -- Price Target Lowered to $225 - GuruFocus
Tenet Healthcare (NYSE:THC) Given New $252.00 Price Target at Guggenheim - MarketBeat
Wells Fargo & Company Issues Pessimistic Forecast for Tenet Healthcare (NYSE:THC) Stock Price - MarketBeat
KeyCorp Lowers Tenet Healthcare (NYSE:THC) Price Target to $225.00 - MarketBeat
Brokers Suggest Investing in Tenet (THC): Read This Before Placing a Bet - Yahoo Finance
Tenet Healthcare Corporation (NYSE:THC) Q1 2026 Earnings Call Transcript - Insider Monkey
Cost management, outpatient unit helped Tenet weather volume headwinds in Q1 - Yahoo Finance
KeyBanc lowers Tenet Healthcare stock price target on valuation - Investing.com
KeyBanc lowers Tenet Healthcare stock price target on valuation By Investing.com - Investing.com UK
Tenet Healthcare Corp (THC) Q1 2026 Earnings Call Highlights: St - GuruFocus
Tenet Healthcare (NYSE:THC) Posts Earnings Results, Beats Expectations By $0.63 EPS - MarketBeat
Tenet Healthcare Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Net income surges at Tenet Healthcare (NYSE: THC) on CHI contract exit - Stock Titan
Tenet Healthcare Blames Admissions Mix For Soft Q1 Sales - Benzinga
Vanguard files Schedule 13G: Tenet Healthcare (NYSE: THC) 5.26% stake - Stock Titan
Tenet Healthcare Q1 2026 slides: EBITDA beats, USPI growth continues - Investing.com
Earnings call transcript: Tenet Healthcare’s Q1 2026 EPS beats, stock dips - Investing.com
Tenet (THC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Transcript: Tenet Healthcare Q1 2026 Earnings Conference Call - Benzinga
Tenet Healthcare (NYSE:THC) Updates FY 2026 Earnings Guidance - MarketBeat
Q1 2026 Tenet Healthcare Corp Earnings Call Transcript - GuruFocus
Tenet Healthcare (THC) Reports Q1 Earnings, EPS Beats Expectatio - GuruFocus
Is Tenet Healthcare (THC) Overvalued After Q1 2026? GAAP EPS $8. - GuruFocus
Tenet Healthcare (THC) Confirms FY26 Adjusted EBITDA Forecast - GuruFocus
Tenet Healthcare Releases Q1 2026 Financial Results - AlphaStreet
Tenet Healthcare (THC) Q1 Earnings Top Estimates - Yahoo Finance
Tenet Healthcare (NYSE:THC) Posts Q1 CY2026 Sales In Line With Estimates - Barchart.com
Tenet Healthcare beats profit estimates despite revenue miss - Investing.com
Finanzdaten der Tenet Healthcare Corp-Aktie (THC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.22%
0.98%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):